Predictmedix Inc. Announces Sales Contract for the Caribbean Region Along with Strategic Appointments and Key Partnership

   |   Press Releases

TORONTO, ON / ACCESSWIRE / June 4, 2020 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce the execution of a sales contract for its COVID-19 screening technology for the Caribbean region along with key partnerships and appointments to further bolster its position as being the provider of novel artificial intelligence (“AI”) based solutions for workplace health, safety and compliance.


Sales Agreement for COVID-19 Screening – Caribbean

Predictmedix is pleased to announce the execution of a sales contract with Caribbean Digital Media Academy (CDMA), a services integrator company registered in Jamaica that commenced operations in 2015. CDMA specializes in; development, deployment and management of highly immersive joint smart IT solutions. Predictmedix is also pleased to announce strategic developments for the development of its mental health screening technologies.

CDMA will act as a distributor for Predictmedix technology for the Caribbean with a specific focus on government and hospitality sectors. Predictmedix technology will be deployed using a software as a service (“SaaS”) model whereby for every camera or scanner installation, there will be an upfront customization fee followed by a monthly subscription fee model based on the number of screenings contributing to recurring revenue on a monthly basis. The recurring revenue will be shared between Predictmedix and CDMA.

Some of the projects successfully implemented by CDMA in their short history include: designed and implemented exclusive encrypted wireless island wide network for the Jamaica Earthquake unit that involved connecting wirelessly over 80 remote seismic solar powered devices for real time monitoring and information by the central unit at University of the West Indies (UWI); designed and implemented real time smart video monitoring by police, government departments and authorized private sector organizations of highly sensitive scrap metal sites in Jamaica. The contract included designing and integrating an exclusive wireless network, artificial intelligence (AI) security software and IP CCTV camera systems.

Havian Harris, head of customer relations at CDMA said, “we are elated to work with Predictmedix as their COVID-19 detection fits in with our sweet spot of successfully promoting and integrating highly sensitive video solutions with their AI software”. She further went on to state, “Our Caribbean nations are highly dependent on tourism and the Predictmedix solution will allow us to participate in opening back up our hospitality and transportation industries that are so crucial to our economies”.


Key appointment – Business Development and Strategy

Predictmedix is also pleased to announce the appointment of Mr. Prabhakar Srivastava, a Senior Healthcare Executive with over 38+ years’ experience including being the CEO of an Indo-Israel Venture and more than a decade as an independent consultant & mentor. Mr Srivastava will be playing a pivotal role in business development, deployment and strategic partnerships in Asia Pacific and Africa for all the technologies developed and being developed by Predictmedix.

Mr Srivastava has been pivotal in launching state-of-the-art innovative solutions for indigenous production through Transfer of Technology in healthcare & environment fields from companies including Phillips Medical Systems, Picker International Inc, Elscint Ltd., Medison Co. Ltd. and Toshiba Corporation. Additionally, he has served as advisor to several African Countries viz. Uganda, Republic of Burundi & Federal Republic of Nigeria along with the government of India.


Partnership – Mental Health Screening Technology

Predictmedix is developing AI powered technologies to assist with diagnosis and management of mental health disorders such as depression, autism, ADHD and dementia. Predictmedix is pleased to announce a partnership with Max Healthcare for facial technologies leading to neurological diagnostics for mental health disorders. Max Healthcare is one of the largest healthcare groups in South Asia, encompassing 14 hospitals with over 3000 doctors. Max Healthcare will be assisting Predictmedix with data collection for the mental health screening technology and will also be piloting the technology.


Key appointment – Healthcare

Predictmedix is pleased to welcome, Dr. Deepu Banerji, a neurosurgeon with more than 34 years’ experience in microscopic and minimal invasive neurosurgery. He is a ‘Sugita Fellow’ from Nagoya University, Japan for microneuro-surgical training and has been consistently ranked amongst the top 5 neurosurgeons in India.

Dr. Banerji will play a key role in assisting Predictmedix with the development of AI technologies to screen for mental health disorders using patient data. Dr. Banerji has performed over 8,000 surgeries and has served as a board member for several prominent Neurology societies in Asia. He is a Member Editorial Board of Surgical Neurology International and has been conferred Honorary Member of Society of Neurosurgeons of South Africa.

“In addition to progressing with deployment of our COVID-19 technology we are actively working on development and deployment of impairment and mental health screening technologies. The current developments are the key in positioning us not only at the forefront of healthcare technologies but also in positioning Predictmedix as the go-to-company for enterprise solutions for workplace health, safety and compliance”, commented Dr. Rahul Kushwah, COO of Predictmedix.

Disclaimer: The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.


For more details on this release please watch the following video interview: